EluciData's mission is to transform the way data is used to drive decisions in R&D labs. We have created Polly, an end to end, vendor-neutral, cloud-based platform that standardizes and streamlines omics data analysis workflows, as well as integrates various forms of omics data to understand cellular phenotype. The Polly platform analyzes and integrates data across genomics, epigenomics, transcriptomics, proteomics, metabolomics, and microbiomics, providing enhanced insights into the underlying biology of a particular cell. Our integration workflows allow scientists to combine various omics datasets in order to more rapidly advance biological research. Our custom algorithms reduce omics data processing time from weeks to literally minutes, quickly giving researchers insightful results and clear follow-on directions in which to move. Our on-demand service offerings include collecting, curating, and analyzing biological data as well as creating custom software product offerings to assist clients in their efforts to better identify and validate biological targets, speeding development of an organization's scientific and therapeutics assets.
SCIEX, a global leader in life science analytical technologies, today announced a Co-marketing agreement with Elucidata, a disruptive integrated Omics platform company providing tools for metabolomics data processing. This relationship will uniquely position SCIEX to address the major challenges f... (more)
Working with some of the biggest and most innovative organizations - including Pfizer, Cygnal, MIT, Yale & Princeton
Expanding global footprint with new offices in Bangalore and San Francisco
Increasing the talent base with senior leadership hiring in India & US.(more)
